Quality Assurance Officer, Kelly Ward has been with Hart Biologicals for over two years and in that time has become an integral part of the QA Department.
Managing Director of Hart Biologicals, Alby Pattison MBE gives his opinion on current thinking towards DOAC and Warfarin.
In its mission to further help graduates and students from across the region find their first foot on the career ladder, Hart Biologicals has welcomed four work experience students on their yearlong placements.
Heroic Hartlepool finished in an excellent third place on their second entry into the Bangkok International Rugby Sevens.
Hartlepool's United rugby team is ready to fly the flag again at a major overseas sporting spectacular - thanks to heavyweight businesses packing a sponsorship punch.
Hart Biologicals is proud to announce the launch for a new product in a novel venture with international partner, Fiix Diagnostics.
Experts from top medical appliance company, Hart Biologicals, are taking to the road to unveil a brand-new product at two major exhibitions.
Staff at Hart Biologicals have shown their support to Macmillan Cancer Support with its annual coffee morning raising more than £452.
As part of Hart Biologicals’ expansion of its range of platelet aggregation reagents, the specialist medical machinery manufacturer is also introducing its own custom-branded multiple electrode aggregometry (MEA) adapter to the market.
Over the past 12 months, Hart Innovations’ Research and Development Scientist Shelley James has been working with Manchester University as part of a Knowledge Transfer Partnership (KTP).
As part of the company’s ongoing passion for supporting local sporting teams, Hart Biologicals will be helping Hartlepool rugby to make its second tilt at a major overseas tournament by entering the Bangkok International Sevens again.
Hart Biologicals, the UK-based expert in cutting-edge in-vitro diagnostics, is expanding its product range in the global haemostasis market.